Goldberg discussed the FDA approval of Vabysmo (faricimab, Genentech) for the treatment of retinal vein occlusion (RVO) and the possible label expansion of high-dose aflibercept for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback